Transcutaneous Electrical Nerve Stimulation Market Size 2031

Transcutaneous Electrical Nerve Stimulation Market Size 2031

Segments - Transcutaneous Electrical Nerve Stimulation Market by Type (Desktop and Portable), Application (Acute Pain and Chronic Pain), End-user (Clinics, Hospitals, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-5836 | 4.7 Rating | 54 Reviews | 191 Pages | Format : PDF Excel PPT

Report Description


Transcutaneous Electrical Nerve Stimulation Market Outlook 2031

The global transcutaneous electrical nerve stimulation market size was USD 310.29 Million in 2022 and is likely to reach USD 429.46 Million by 2031, expanding at a CAGR of 3.87% during 2023–2031. High demand for pain management therapies and devices is anticipated to propel the market.

Growing prevalence of chronic pain conditions is projected to propel the market during the forecast period. In recent years, there has been an increasing requirement for transcutaneous electrical nerve stimulation among athletes and sports enthusiasts. Furthermore, the high demand for non-invasive pain management in the geriatric demographic, due to the surge in the geriatric population is likely to fuel the market in the coming years.

  • According to the data published by the World Health Organization (WHO) in 2022, the global population of individuals aged 60 years or older exceeded the number of children aged below five years in 2020. It is projected that nearly 80% of the elderly population is expected to reside in underdeveloped and developing countries by 2050.

Transcutaneous Electrical Nerve Stimulation Market Outlook

The technological advancements have led to significant improvements in transcutaneous electrical nerve stimulation devices in terms of features and connectivity. The awareness of alternative pain management treatments and therapies is rising among the population. Thus, people are increasingly opting for non-pharmacological treatments for drug-free pain relief. These factors are anticipated to boost the market in the coming years.

The COVID-19 pandemic hindered the market. Most of the healthcare resources shifted their focus to treating the infected patients during the pandemic, which decreased the demand for pain management and related therapies. This, in turn, affected the market, as the demand for transcutaneous electrical nerve stimulation devices significantly declined.

Impact of Artificial Intelligence (AI) on Transcutaneous Electrical Nerve Stimulation Market

The adoption of artificial intelligence is expected to provide substantial propulsion to the transcutaneous electrical nerve stimulation market. The convergence of artificial intelligence (AI), the Internet of Things (IoT), and health monitoring sensors have made it possible to establish a closed-loop system that offers real-time monitoring, data collection, and treatment recommendations. The use of transcutaneous electrical nerve stimulation sensors enhanced by intelligent technologies is vital in terms of providing effective treatment to patients.

Transcutaneous Electrical Nerve Stimulation Market Dynamics

Transcutaneous Electrical Nerve Stimulation Market Dynamics

Major Drivers

Increasing advancements in the technology of electrotherapy devices are expected to drive the market during the projection period. Advanced transcutaneous electrical nerve stimulation (TENS) devices offer features, such as customizable settings for treatment, wireless connectivity, and smartphone applications for remote monitoring and control. These technological innovations enhance the user experience and treatment. The use of such technology makes TENS devices appealing to a wide range of patients, thereby boosting the market.

Existing Restraints

Problems associated with the use of TENS devices, such as skin irritation, are likely to hamper the market during the forecast period. TENS devices require the placement of adhesive electrodes on the skin, which causes discomfort or irritation. This discourages people from using these devices as a treatment option, which impedes the market during the forecast period.

Emerging Opportunities

Surge in product innovation is anticipated to provide substantial growth opportunities for the market. Innovative TENS devices are leading to advanced features and enhanced user experience. The development of portable, compact, and wearable TENS devices is appealing to a large consumer base. In addition, these devices are efficient and user-friendly.

  • In March 2022, a study by the European Pain Federation supported by several US universities found that the OMRON FocusTM TENS Therapy for the knee (PM-710) device is effective in diminishing pain for people with mild to moderate knee problems, such as wear and tear. It proved to be highly useful, especially during functional tests, such as walking and stair climbing.

Scope of the Transcutaneous Electrical Nerve Stimulation Market Report

The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Transcutaneous Electrical Nerve Stimulation Market – Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016–2021

Forecast Period

2023–2031

Segmentation

Type (Desktop and Portable), Application (Acute Pain and Chronic Pain), and End-user (Clinics, Hospitals, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast

Key Players Covered in the Report

Zynex Medical; Uroplasty, Inc.; NEVRO CORP.; NeuroMetrix, Inc.; Medtronic; DJO, LLC; Cyberonic Internet Communications, Inc.; BTL Group of Companies; Boston Scientific Corporation; and Abbott

Transcutaneous Electrical Nerve Stimulation Market Segment Insights

Type Segment Analysis

Based on type, the transcutaneous electrical nerve stimulation market is bifurcated into desktop and portable. The portable segment is projected to hold the major share of the market during the projection period, owing to its ease of use and convenient functionality. Portable transcutaneous electrical nerve stimulation (TENS) devices are often designed with user-friendly interfaces.

This makes them easy to operate without any professional assistance. Furthermore, portable TENS devices allow therapy on the go, providing relief from pain at home, work, or any other location. This makes them highly convenient, thereby boosting the segment.

Transcutaneous Electrical Nerve Stimulation Market Type

Application Segment Analysis

On the basis of application, the global market is segregated into acute pain and chronic pain. The acute pain segment is further segregated into sports injuries, labor pain, postoperative pain, and menstrual pain. Similarly, the chronic pain segment is divided into arthritis, fibromyalgia, back & neck pain, neuropathic pain, and others.

The acute pain segment is projected to register a considerable CAGR during the forecast period, as TENS devices offer a non-invasive method for managing acute pain. This is especially beneficial when immediate relief is needed without resorting to medication or invasive procedures. Moreover, these devices provide quick relief by stimulating the body’s natural pain management system. This makes it a valuable tool for sudden and severe acute pain, such as post-operative pain and acute injuries. This, in turn, propel the segment.

The chronic pain segment is anticipated to grow rapidly during the projection period, as TENS devices are available in compact and portable forms, making them suitable for use at homes and offices for people suffering from chronic pain. These devices provide a drug-free and non-invasive method of chronic pain management while allowing for a wide range of customizations for specific needs, thereby fueling the segment.

  • According to a report published by the Centers for Disease Control and Prevention in April 2023, approximately 51.6 million adults (20.9%) in the US experienced chronic pain in 2021. Of these, 17.1 million people (6.9%) had high-impact chronic pain, which severely limits their daily activities. Alaska Native adults or non-Hispanic American Indians, adults identifying as bisexual, and people who were separated or divorced were more likely to report high-impact chronic pain.

Transcutaneous Electrical Nerve Stimulation Market Application

End-user Segment Analysis

Based on end-user, the transcutaneous electrical nerve stimulation market is divided into clinics, hospitals, and others. The clinics segment is anticipated to register a robust growth rate during the projection period, owing to the availability of specialized equipment and trained professionals that allows for the customization of TENS therapy devices based on an individual’s needs.

This helps in safe and effective pain management. In addition, the clinics closely monitor the patient’s progress in the therapy, making real-time adjustments and providing valuable feedback, thereby fueling the segment.

Regional Outlook

In terms of region, the global transcutaneous electrical nerve stimulation market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projection period, due to its excellent healthcare analytics system, the presence of several key players, and advanced medical infrastructure.

The rising investments by the governments to develop advanced medical devices are creating potential growth opportunities for the market. In addition, the high disposable income of the consumers and the rising adoption of advanced medical devices and innovative technologies are anticipated to propel the market.


The market in Asia Pacific is projected to expand at a considerable CAGR in the coming years, owing to the increasing awareness of general fitness and health. The high adoption of therapies for pain management and the surging use of smart devices in the health and fitness industry are some of the primary factors responsible for the growth of the market in the region.

Furthermore, the surge in the geriatric population in countries, such as China and Japan, is projected to propel the market during the forecast period.

Transcutaneous Electrical Nerve Stimulation Market Region

Segments

The transcutaneous electrical nerve stimulation market has been segmented on the basis of

Type

  • Desktop
  • Portable

Application

  • Acute Pain
    • Sports Injuries
    • Labor Pain
    • Postoperative Pain
    • Menstrual Pain
  • Chronic Pain
    • Arthritis
    • Fibromyalgia
    • Back & Neck Pain
    • Neuropathic Pain
    • Others

End-user

  • Clinics
  • Hospitals
  • Others

Region

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Zynex Medical
  • Uroplasty, Inc.
  • NEVRO CORP.
  • NeuroMetrix, Inc.
  • Medtronic
  • DJO, LLC
  • Cyberonic Internet Communications, Inc.
  • BTL Group of Companies
  • Boston Scientific Corporation
  • Abbott

Competitive Landscape

Key players competing in the global transcutaneous electrical nerve stimulation market are Zynex Medical; Uroplasty, Inc.; NEVRO CORP.; NeuroMetrix, Inc.; Medtronic; DJO, LLC; Cyberonic Internet Communications, Inc.; BTL Group of Companies; Boston Scientific Corporation; and Abbott.

These companies adopt numerous development strategies, such as acquisitions, mergers, collaboration, partnerships, product launches, and production expansion, to tap into the untapped regions. These key market players heavily invest in the R&D of innovative devices and treatments to maintain market relevance. For instance,

  • In April 2021, DJO, LLC, one of the prominent market players, acquired MedShape, Inc., a key provider of innovative surgical solutions for ankle and foot surgeons, to help with soft tissue injury repair, fracture fixation, and joint fusion. This acquisition is intended to help DJO, LLC to expand its business in foot and ankle surgeries.

Transcutaneous Electrical Nerve Stimulation Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Transcutaneous Electrical Nerve Stimulation Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Transcutaneous Electrical Nerve Stimulation Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Transcutaneous Electrical Nerve Stimulation Market - Supply Chain
  4.5. Global Transcutaneous Electrical Nerve Stimulation Market Forecast
     4.5.1. Transcutaneous Electrical Nerve Stimulation Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Transcutaneous Electrical Nerve Stimulation Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Transcutaneous Electrical Nerve Stimulation Market Absolute $ Opportunity
5. Global Transcutaneous Electrical Nerve Stimulation Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Transcutaneous Electrical Nerve Stimulation Market Size and Volume Forecast by Types
     5.3.1. Desktop
     5.3.2. Portable
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Transcutaneous Electrical Nerve Stimulation Market Analysis and Forecast by Applications
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Applications
     6.2.2. Y-o-Y Growth Projections by Applications
  6.3. Transcutaneous Electrical Nerve Stimulation Market Size and Volume Forecast by Applications
     6.3.1. Acute Pain
     6.3.2. Chronic Pain
  6.4. Absolute $ Opportunity Assessment by Applications
  6.5. Market Attractiveness/Growth Potential Analysis by Applications
7. Global Transcutaneous Electrical Nerve Stimulation Market Analysis and Forecast by End Users
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by End Users
     7.2.2. Y-o-Y Growth Projections by End Users
  7.3. Transcutaneous Electrical Nerve Stimulation Market Size and Volume Forecast by End Users
     7.3.1. Clinics
     7.3.2. Hospitals
     7.3.3. Others
  7.4. Absolute $ Opportunity Assessment by End Users
  7.5. Market Attractiveness/Growth Potential Analysis by End Users
8. Global Transcutaneous Electrical Nerve Stimulation Market Analysis and Forecast by Region
  8.1. Market Trends
  8.2. Introduction
     8.2.1. Basis Point Share (BPS) Analysis by Region
     8.2.2. Y-o-Y Growth Projections by Region
  8.3. Transcutaneous Electrical Nerve Stimulation Market Size and Volume Forecast by Region
     8.3.1. North America
     8.3.2. Latin America
     8.3.3. Europe
     8.3.4. Asia Pacific
     8.3.5. Middle East and Africa (MEA)
  8.4. Absolute $ Opportunity Assessment by Region
  8.5. Market Attractiveness/Growth Potential Analysis by Region
  8.6. Global Transcutaneous Electrical Nerve Stimulation Demand Share Forecast, 2019-2026
9. North America Transcutaneous Electrical Nerve Stimulation Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
  9.2. North America Transcutaneous Electrical Nerve Stimulation Market Size and Volume Forecast by Country
     9.2.1. U.S.
     9.2.2. Canada
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. North America Transcutaneous Electrical Nerve Stimulation Market Size and Volume Forecast by Types
     9.4.1. Desktop
     9.4.2. Portable
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. North America Transcutaneous Electrical Nerve Stimulation Market Size and Volume Forecast by Applications
     9.7.1. Acute Pain
     9.7.2. Chronic Pain
  9.8. Basis Point Share (BPS) Analysis by Applications
  9.9. Y-o-Y Growth Projections by Applications
  9.10. North America Transcutaneous Electrical Nerve Stimulation Market Size and Volume Forecast by End Users
     9.10.1. Clinics
     9.10.2. Hospitals
     9.10.3. Others
  9.11. Basis Point Share (BPS) Analysis by End Users
  9.12. Y-o-Y Growth Projections by End Users
  9.13. Market Attractiveness/Growth Potential Analysis
     9.13.1. By Country
     9.13.2. By Product Type
     9.13.3. By Application
  9.14. North America Transcutaneous Electrical Nerve Stimulation Demand Share Forecast, 2019-2026
10. Latin America Transcutaneous Electrical Nerve Stimulation Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Latin America Average Pricing Analysis
  10.2. Latin America Transcutaneous Electrical Nerve Stimulation Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
  10.4. Latin America Transcutaneous Electrical Nerve Stimulation Market Size and Volume Forecast by Types
     10.4.1. Desktop
     10.4.2. Portable
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Latin America Transcutaneous Electrical Nerve Stimulation Market Size and Volume Forecast by Applications
     10.7.1. Acute Pain
     10.7.2. Chronic Pain
  10.8. Basis Point Share (BPS) Analysis by Applications
  10.9. Y-o-Y Growth Projections by Applications
  10.10. Latin America Transcutaneous Electrical Nerve Stimulation Market Size and Volume Forecast by End Users
     10.10.1. Clinics
     10.10.2. Hospitals
     10.10.3. Others
  10.11. Basis Point Share (BPS) Analysis by End Users
  10.12. Y-o-Y Growth Projections by End Users
  10.13. Market Attractiveness/Growth Potential Analysis
     10.13.1. By Country
     10.13.2. By Product Type
     10.13.3. By Application
  10.14. Latin America Transcutaneous Electrical Nerve Stimulation Demand Share Forecast, 2019-2026
11. Europe Transcutaneous Electrical Nerve Stimulation Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Europe Average Pricing Analysis
  11.2. Europe Transcutaneous Electrical Nerve Stimulation Market Size and Volume Forecast by Country
     11.2.1. Germany
     11.2.2. France
     11.2.3. Italy
     11.2.4. U.K.
     11.2.5. Spain
     11.2.6. Russia
     11.2.7. Rest of Europe
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Europe Transcutaneous Electrical Nerve Stimulation Market Size and Volume Forecast by Types
     11.4.1. Desktop
     11.4.2. Portable
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Europe Transcutaneous Electrical Nerve Stimulation Market Size and Volume Forecast by Applications
     11.7.1. Acute Pain
     11.7.2. Chronic Pain
  11.8. Basis Point Share (BPS) Analysis by Applications
  11.9. Y-o-Y Growth Projections by Applications
  11.10. Europe Transcutaneous Electrical Nerve Stimulation Market Size and Volume Forecast by End Users
     11.10.1. Clinics
     11.10.2. Hospitals
     11.10.3. Others
  11.11. Basis Point Share (BPS) Analysis by End Users
  11.12. Y-o-Y Growth Projections by End Users
  11.13. Market Attractiveness/Growth Potential Analysis
     11.13.1. By Country
     11.13.2. By Product Type
     11.13.3. By Application
  11.14. Europe Transcutaneous Electrical Nerve Stimulation Demand Share Forecast, 2019-2026
12. Asia Pacific Transcutaneous Electrical Nerve Stimulation Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Asia Pacific Average Pricing Analysis
  12.2. Asia Pacific Transcutaneous Electrical Nerve Stimulation Market Size and Volume Forecast by Country
     12.2.1. China
     12.2.2. Japan
     12.2.3. South Korea
     12.2.4. India
     12.2.5. Australia
     12.2.6. Rest of Asia Pacific (APAC)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Asia Pacific Transcutaneous Electrical Nerve Stimulation Market Size and Volume Forecast by Types
     12.4.1. Desktop
     12.4.2. Portable
  12.5. Basis Point Share (BPS) Analysis by Types
  12.6. Y-o-Y Growth Projections by Types
  12.7. Asia Pacific Transcutaneous Electrical Nerve Stimulation Market Size and Volume Forecast by Applications
     12.7.1. Acute Pain
     12.7.2. Chronic Pain
  12.8. Basis Point Share (BPS) Analysis by Applications
  12.9. Y-o-Y Growth Projections by Applications
  12.10. Asia Pacific Transcutaneous Electrical Nerve Stimulation Market Size and Volume Forecast by End Users
     12.10.1. Clinics
     12.10.2. Hospitals
     12.10.3. Others
  12.11. Basis Point Share (BPS) Analysis by End Users
  12.12. Y-o-Y Growth Projections by End Users
  12.13. Market Attractiveness/Growth Potential Analysis
     12.13.1. By Country
     12.13.2. By Product Type
     12.13.3. By Application
  12.14. Asia Pacific Transcutaneous Electrical Nerve Stimulation Demand Share Forecast, 2019-2026
13. Middle East & Africa Transcutaneous Electrical Nerve Stimulation Market Analysis and Forecast
  13.1. Introduction
     13.1.1. Basis Point Share (BPS) Analysis by Country
     13.1.2. Y-o-Y Growth Projections by Country
     13.1.3. Middle East & Africa Average Pricing Analysis
  13.2. Middle East & Africa Transcutaneous Electrical Nerve Stimulation Market Size and Volume Forecast by Country
     13.2.1. Saudi Arabia
     13.2.2. South Africa
     13.2.3. UAE
     13.2.4. Rest of Middle East & Africa (MEA)
  13.3. Absolute $ Opportunity Assessment by Country
  13.4. Middle East & Africa Transcutaneous Electrical Nerve Stimulation Market Size and Volume Forecast by Types
     13.4.1. Desktop
     13.4.2. Portable
  13.5. Basis Point Share (BPS) Analysis by Types
  13.6. Y-o-Y Growth Projections by Types
  13.7. Middle East & Africa Transcutaneous Electrical Nerve Stimulation Market Size and Volume Forecast by Applications
     13.7.1. Acute Pain
     13.7.2. Chronic Pain
  13.8. Basis Point Share (BPS) Analysis by Applications
  13.9. Y-o-Y Growth Projections by Applications
  13.10. Middle East & Africa Transcutaneous Electrical Nerve Stimulation Market Size and Volume Forecast by End Users
     13.10.1. Clinics
     13.10.2. Hospitals
     13.10.3. Others
  13.11. Basis Point Share (BPS) Analysis by End Users
  13.12. Y-o-Y Growth Projections by End Users
  13.13. Market Attractiveness/Growth Potential Analysis
     13.13.1. By Country
     13.13.2. By Product Type
     13.13.3. By Application
  13.14. Middle East & Africa Transcutaneous Electrical Nerve Stimulation Demand Share Forecast, 2019-2026
14. Competition Landscape
  14.1. Global Transcutaneous Electrical Nerve Stimulation Market: Market Share Analysis
  14.2. Transcutaneous Electrical Nerve Stimulation Distributors and Customers
  14.3. Transcutaneous Electrical Nerve Stimulation Market: Competitive Dashboard
  14.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     14.4.1. Zynex Medical
     14.4.2. Uroplasty, Inc.
     14.4.3. NEVRO CORP.
     14.4.4. NeuroMetrix, Inc.
     14.4.5. Medtronic
     14.4.6. DJO, LLC
     14.4.7. Cyberonic Internet Communications, Inc.
     14.4.8. BTL Group of Companies
     14.4.9. Boston Scientific Corporation
     14.4.10. Abbott

Methodology

Our Clients

Dassault Aviation
Microsoft
Nestle SA
The John Holland Group
sinopec
FedEx Logistics
General Electric
Deloitte